These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The acute and chronic administration of (+/-)-8-hydroxy-2-(Di-n-propylamino)tetralin significantly alters the activity of spontaneously active midbrain dopamine neurons in rats: an in vivo electrophysiological study. Nakamura K; Suzuki K; McCreary AC; Ashby CR Synapse; 2006 May; 59(6):359-67. PubMed ID: 16463399 [TBL] [Abstract][Full Text] [Related]
3. The 5-HT1A receptor antagonist (S)-UH-301 blocks the qR)-8-OH-DPAT-induced inhibition of serotonergic dorsal raphe cell firing in the rat. Arborelius L; Höök BB; Hacksell U; Svensson TH J Neural Transm Gen Sect; 1994; 96(3):179-86. PubMed ID: 7826569 [TBL] [Abstract][Full Text] [Related]
4. Prazosin modulates the changes in firing pattern and transmitter release induced by raclopride in the mesolimbic, but not in the nigrostriatal dopaminergic system. Andersson JL; Marcus M; Nomikos GG; Svensson TH Naunyn Schmiedebergs Arch Pharmacol; 1994 Mar; 349(3):236-43. PubMed ID: 7911558 [TBL] [Abstract][Full Text] [Related]
5. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats. Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310 [TBL] [Abstract][Full Text] [Related]
6. Evidence for specific interactions between 5-HT1A and dopamine D2 receptor mechanisms in the mediation of extrapyramidal motor functions in the rat. Wadenberg ML; Cortizo L; Ahlenius S Pharmacol Biochem Behav; 1994 Mar; 47(3):509-13. PubMed ID: 8208768 [TBL] [Abstract][Full Text] [Related]
7. Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system. Andersson JL; Nomikos GG; Marcus M; Hertel P; Mathé JM; Svensson TH Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):374-85. PubMed ID: 8532065 [TBL] [Abstract][Full Text] [Related]
8. Monoamine interactions measured by microdialysis in the ventral tegmental area of rats treated systemically with (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin. Chen NH; Reith ME J Neurochem; 1995 Apr; 64(4):1585-97. PubMed ID: 7891086 [TBL] [Abstract][Full Text] [Related]
9. Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo. Prisco S; Pagannone S; Esposito E J Pharmacol Exp Ther; 1994 Oct; 271(1):83-90. PubMed ID: 7965760 [TBL] [Abstract][Full Text] [Related]
10. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin. Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561 [TBL] [Abstract][Full Text] [Related]
11. The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum. Nomikos GG; Arborelius L; Höök BB; Hacksell U; Svensson TH J Neural Transm (Vienna); 1996; 103(5):541-54. PubMed ID: 8811500 [TBL] [Abstract][Full Text] [Related]
12. The mechanism by which the selective 5-HT1A receptor antagonist S-(-) UH 301 produces head-twitches in mice. Darmani NA; Reeves SL Pharmacol Biochem Behav; 1996 Sep; 55(1):1-10. PubMed ID: 8870031 [TBL] [Abstract][Full Text] [Related]
13. The novel 5-HT1A receptor antagonist (S)-UH-301 prevents (R)-8-OH-DPAT-induced decrease in interstitial concentrations of serotonin in the rat hippocampus. Nomikos GG; Arborelius L; Svensson TH Eur J Pharmacol; 1992 Jun; 216(3):373-8. PubMed ID: 1425929 [TBL] [Abstract][Full Text] [Related]
14. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone. Protais P; Lesourd M; Comoy E Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353 [TBL] [Abstract][Full Text] [Related]
15. Pindolol excites dopaminergic and adrenergic neurons, and inhibits serotonergic neurons, by activation of 5-HT1A receptors. Lejeune F; Millan MJ Eur J Neurosci; 2000 Sep; 12(9):3265-75. PubMed ID: 10998110 [TBL] [Abstract][Full Text] [Related]
16. Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal firing of the midbrain raphe nuclei 5-HT neurons and a decrease of their response to 5-HT(1A) receptor stimulation in the rat. Wang S; Zhang QJ; Liu J; Wu ZH; Wang T; Gui ZH; Chen L; Wang Y Neuroscience; 2009 Mar; 159(2):850-61. PubMed ID: 19174182 [TBL] [Abstract][Full Text] [Related]
17. The novel 5-HT1A receptor antagonist (S)-UH-301 antagonizes 8-OH-DPAT-induced effects on male as well as female rat copulatory behaviour. Johansson CE; Meyerson BJ; Hacksell U Eur J Pharmacol; 1991 Sep; 202(1):81-7. PubMed ID: 1838499 [TBL] [Abstract][Full Text] [Related]
18. 5-HT1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram. Arborelius L; Nomikos GG; Grillner P; Hertel P; Höök BB; Hacksell U; Svensson TH Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):157-65. PubMed ID: 7477438 [TBL] [Abstract][Full Text] [Related]
19. Electrophysiological comparison of 5-Hydroxytryptamine1A receptor antagonists on dorsal raphe cell firing. Martin LP; Jackson DM; Wallsten C; Waszczak BL J Pharmacol Exp Ther; 1999 Feb; 288(2):820-6. PubMed ID: 9918594 [TBL] [Abstract][Full Text] [Related]
20. Modulation of the activity of central serotoninergic neurons by novel serotonin1A receptor agonists and antagonists: a comparison to adrenergic and dopaminergic neurons in rats. Gobert A; Lejeune F; Rivet JM; Audinot V; Newman-Tancredi A; Millan MJ J Pharmacol Exp Ther; 1995 Jun; 273(3):1032-46. PubMed ID: 7791073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]